Successful Disease Management Programs Can Play Role in Health Care Reform
...ember 20, 2004; Vol. 14, No. 48.
(6) MO's Pharmacy Program Decreases Hospitalization for Medicaid SMI Patients. Mental Health Weekly. Dec. 12, 2005; vol
15:Number 47, 1-3.
(7) Kenneth E. Thorpe, "Prevention and Public Health: The Key to Transforming our Sickcare System," (Written testimony to the U.S...
A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
... This global action coincides with the publishing of Dr. Gallo and his colleagues' four key groundbreaking articles in Science magazine, May 4, 1984 vol
224 (#4648). These four papers proved how the then-new, deadly virus was the cause of AIDS. This significant global contribution lead to the developm...
JumpStart and Case Technology Ventures Invest in Neuros Medical
...er undergoing limb amputation due to vascular disease, circulatory issues, diabetes, cancer or trauma-related events. According to Arch Phys Med Rehab vol
86, Oct 2005, 68 to 76 percent of the 1.7 million U.S. patients who have undergone amputation experience residual limb pain. This number is expected ...
Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients
...detected contralateral cancer. The positive predictive value for BSGI was 92.9%.
The full study can be found in The American Journal of Surgery, vol
197, No 2, February 2009.
About Dilon Technologies
Dilon Technologies Inc. is bringing innovative new medical imaging products to market. ...
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Health Statistics Vital and Health Statistics, Detailed diagnoses
and procedures national hospital discharge survey 1994. vol
Hyattsville (MD): Department of Health and Human Services; 1997.
(3) Healthcare-Associated Methicillin Resistant Staphylococcus ...
New criteria for measuring tumor size and progression will help ease workloads in clinical trials
...reaching them sooner."
This release is embargoed to 00.01 hrs (GMT) on Tuesday 20 January 2009.
 European Journal of Cancer, vol
45, issue 2 (January 2009), pages 225-310. "Response assessment in solid tumours (RECIST): Version 1.1 and supporting papers."
The European Journal...
Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers
...of black tea, the equivalent of three or four cups a day, they were protected against the effects of a known carcinogen (Food and Chemical Toxicology, vol
38, p. 1085).
The new Amanzi Tea bar and shop is located at 166 Chambers Street near Greenwich Avenue in Tribeca. Hours are M-Su 7A-7P. Cal...
UCSF Launches Nationwide Clinical Trial Matching Web Site for Breast Cancer
...visit http://www.ucsf.edu .
(1) "Central Challenges Facing the National Clinical Research
Enterprise." Journal of the American Medical Association, vol
289, No. 10.
March 12, 2003.
Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts
...n Sexuality Education: Ideology and the Scientific Process" has been published by Dr. Santelli in the American Journal of Public Health (October 2008, vol
98, no 10) and examines the criteria for determining scientific accuracy and the ways that abstinence-only programs overlook established medical facts...
Hidden Areas of Infection in U.S. Hospitals
... such as administrators and
(1) Jancin, B. (2004, March). Antiobiotic-resistant pathogens found on
77% of ECG lead wires. Cardiology News. vol
(2) Holden, D. (Project Manager). (2008, March). Hidden Areas of
Infection [DVD]. Mission Critical: Capital Media Group; LS-954 - Bon
Vol in Medical Technology
Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
...hase III randomized placebo-controlled
Trial (SHARP trial), Journal of Clinical Oncology, 2007 ASCO Annual
Meeting Proceedings Part I. vol
25, No. 18S (June 20 Supplement),
 Health Risks from Dioxin and Related Compounds, National
Research Council, Natio...
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
...or Aurora B
kinase. Aurora A and B have been shown to be over-expressed in a broad
range of tumours.
4)Hung Huynh et al (2006),Clin Cancer Res;4309, vol
12 (14) July 15
Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections
...2) Klevens, et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Reports, March-April 2007, vol
122, pp. 160-166.
(3) Cardinal Health analysis of 3.1 million admissions across 100 hospitals, 2007.
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
... and strategic partners and other factors described in the
Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.
(1) THE LANCET, vol
361, March 1, 2003
(2) DIABETES CARE, VOLUME 31, NUMBER 4, APRIL 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
...utic as adjuvant therapy in
stage IB/II Non-Small Cell Lung Cancer (NSCLC)' Journal of Clinical
Oncology, 2007 ASCO Annual Meeting Proceedings Part I. vol
25, No. 18S
(June 20 Supplement), 2007: 7554.
(5) http://www.who.int/uv/faq/skincancer/en/index1.html (Date of
access: May 6, 2008).
Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
...educed-intensity autologous stem cell transplantation in elderly patients with multiple myeloma: Results of a randomised IFM trial. The Lancet vol
370 October 6, 2007, pp 1209-1217
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This release contains forward-lo...
AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
... double-blind randomized phase II trial. Journal of Clinical Oncology, vol
24, No 18S, 2006: 7000. (2) Heymach JV et al. Randomized, Placebo-Controll...ously Treated Non-Small-Cell Lung Cancer Journal of Clinical Oncology, vol
25, No 27, 2007: 4270-4277.
Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
...r haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)." The Lancet, vol
370, Pages 1415-1421. October 20, 2007
Mircera Effective in Stabilising Haemoglobin Levels in Elderly
Patients With Kidney Disease on Dialysis
...e Unites States Renal Data
System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in
the United States. American Journal of Kidney Diseases. vol
1, Suppl 1, January 2005
(iv) European Best Practice Guidelines
(v) United States Renal Data System, 2006
(vi) Obrador et al.,...
Nektar Threraputics Announces Phase 2a Clinical Results Regarding
the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative
Hospital-Acquired Pneumonia Presented at the Annual American
Thoracic Society International Conference
the Management of Adults with Hospital-acquired,
Ventilator-associated, and Healthcare-associated Pneumonia," Am J
Respir Crit Care Med, vol
171. pp. 388-416, 2005.)
How often does it occur?
According to the American Thoracic Society, the incidence of
hospital acquired pneumonia is usua...
Vol in Biological Technology
Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
...f California, Berkeley. The
paper and an accompanying commentary appear in the June 2008 print issue of
the magazine, Nature Biotechnology, June 2008, vol
26, 6, pp702-708.
Sigma-Aldrich is a leading Life Science and High...
AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
... double-blind randomized phase II trial. Journal of Clinical Oncology, vol
24, No 18S, 2006: 7000.
(2) Heymach JV et al. Randomized, Placebo-Control...Treated Non-Small-Cell Lung Cancer. Journal of Clinical Oncology 2007, vol
25, No 27, 2007: 4270-4277.
(3) Wedge, S.R et al. ZD6474 inhibits va...
The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
...ts Medical School received an unrestricted grant from
sanofi-aventis to support this work.
(1) Cohen AT, Tapson VF and all. The Lancet vol
(2) Goldhaber SZ, Tapson VF. Am J Cardiol. 2004;93:259-62.
(3) Anderson FA, Jr., Zayaruzny M, Heit JA, Fidan D, Cohen AT.
AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
Not properly detecting real cases of appendicitis is also a major
problem. A large independent research report (Graff et al., 2000 Acad Emerg
7 n 11 pp 1244-55) of approximately 1,026 appendicitis patients
from 12 hospitals across the northeastern United States reported that an
average of 18...
Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services
by law. (1) Giles TD and Rofidal L. Results of the prothrombin office testing benefit evaluation (PROBE), Cardiovascular Review and Reports. vol
XXIII, No. 1, January 2002. (2) Second Quarter 2007 total market share of projected distributor unit sales of the Point of Care Testing Coa...
High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation
...trophic yeast, Pichia pastoris. BIO
2. Brierley, R.A., C. Bussinea... tandem integrations of the gene. BIO/TECHNOLOGY, vol
5. Cregg, J.M., T.S. Vedvick a...cretion from the yeast, Pichia pastoris.
7. Tschopp, J. F., G. Sverlow,...
Separation of Peptides by Hydrophilic Interaction Chromatography Using TSKgel Amide-80
...for alternatives to separating
1. J. Dolan, Retaining Polar Compounds LC/GC vol
5, No. 2 (June 2002)
2. T. Yoshida, Anal Chem. 69 (1997) 3038-3043
3. T. Yoshida, J. Chromatogr. A 808 (1998) 105-112
Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
..., resulting in higher throughput.
(1) C.L. GUILLEMIN - The Deferred Standard Review - Process Control and Quality - vol
6, N 1 (1994) 9-25 Mr. Claude Guillemin 29A boulevard Gorbella - 06100 NICE - France E-mail: Claudeg25@aol.com
(2) J.H. MARSMAN - The Defe...
Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
...rol, data analysis and presentation package.
1. DeLuca, M.A. and W.D. McElroy, (1978) in Meth. Enzymol. vol
Reading with no delay may give slightly better results in view of the fact that both the flash reaction and cell lysis a...
Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39)
2. DeLuca, M.A. and W.D. McElroy, (1978) in Meth. Enzymol. vol
3. Matthews, J.C. et al. (1977) Purification and properties of Renilla reniformis luciferase. Biochemistry, 16:85.